Showing 1 - 5 results of 5 for search 'Erik J. Tillman', query time: 0.04s Refine Results
  1. 1
    FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases

    FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases by Erik J. Tillman, Tim Rolph

    Published 2020-12-01
    Get full text
    Article
  2. 2
    Three months of high-fructose feeding fails to induce excessive weight gain or leptin resistance in mice.

    Three months of high-fructose feeding fails to induce excessive weight gain or leptin resistance in mice. by Erik J Tillman, Donald A Morgan, Kamal Rahmouni, Steven J Swoap

    Published 2014-01-01
    Get full text
    Article
  3. 3
    AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients

    AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients by Allegra Kaufman, Lubna Abuqayyas, William S. Denney, Erik J. Tillman, Tim Rolph

    Published 2020-07-01
    Get full text
    Article
  4. 4
    Global transcriptional regulation of innate immunity by ATF-7 in C. elegans.

    Global transcriptional regulation of innate immunity by ATF-7 in C. elegans. by Marissa Fletcher, Erik J Tillman, Vincent L Butty, Stuart S Levine, Dennis H Kim

    Published 2019-02-01
    Get full text
    Article
  5. 5
    De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling.

    De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling. by Catherine A Del Vecchio, Yuxiong Feng, Ethan S Sokol, Erik J Tillman, Sandhya Sanduja, Ferenc Reinhardt, Piyush B Gupta

    Published 2014-09-01
    Get full text
    Article

Search Tools: